Compare Moderna, Inc. (MRNA) vs abrdn Physical Palladium Shares ETF (PALL) Price & Performance

Moderna, Inc.Trade

abrdn Physical Palladium Shares ETFTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs abrdn Physical Palladium Shares ETF — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while abrdn Physical Palladium Shares ETF trades at $23.31. The key difference: Moderna, Inc. is trading nearer its 52-week high, abrdn Physical Palladium Shares ETF nearer its low. Which is the better fit depends on your goals.

	MRNA	PALL
Market Cap	$23.60B	—
Sector	Health	Commodities - Metals/Agriculture
52-Week High	$81.80	$37.18
52-Week Low	$22.36	$19.96
Enterprise Value	$19.70B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

PALL

View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About abrdn Physical Palladium Shares ETF

PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.